SGLT2 inhibitor/ja: Difference between revisions

@@ Line 156: / Line 156: @@
 {{Main/ja|Discovery and development of gliflozins/ja}}
-<div lang="en" dir="ltr" class="mw-content-ltr">
+== 研究 ==
-== Research ==
+{{Anchor|Research}}
-SGLT2 inhibitors increase circulating [[ketone]] body concentrations. The [[Cardioprotection|cardioprotective]] effects of SGLT2 inhibitors have been attributed to the elevated ketone levels.
+SGLT2阻害薬は循環[[ketone/ja|ケトン体]]濃度を上昇させる。SGLT2阻害薬の[[Cardioprotection/ja|心臓保護]]作用はケトン体濃度の上昇に起因している。
-</div>
 <div lang="en" dir="ltr" class="mw-content-ltr">